금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Insurers face losses as riots in France become ‘like natural catastrophes’
Similar events now expected to occur every year, prompting government efforts to require properties ...
Stock market today: Dow, S&P 500, Nasdaq futures mixed as AI trade rebound stalls
The S&P 500 and Nasdaq pointed lower as the AI trade rebound stalled....
Stocks Mostly Down Pre-Bell as Earnings Take Center Stage
US equity futures were mostly pointing lower on Tuesday as investors await a fresh round of corporat...
5 LNG Megaprojects Poised to Power the Next Gas Boom
The war between the US and Iran has driven up natural gas prices, particularly in Europe and Asia. Asia accounts for nearly 90% of liquefied natural gas (LNG) shipments from key Middle East producers ...
Why Oracle Stock Just Jumped
Oracle shares rallied Thursday after two neoclouds posted blowout earnings, but does this AI tailwind justify the stock's risks?
Japanese Yen stumbles as US Dollar strengthens
USD/JPY is back around the mid-159.00s area, testing the day's highs after rebounding sharply from a low around the 158.60 level.
Akzo Nobel upgraded at Barclays as Q2 marks earnings recovery for European chemicals
Trump administration mulls cut to capital gains tax on home sales - report
L3Harris opens Rhode Island facility to expand undersea training production
Humacyte shares fall after Q2 revenue, EPS miss
Altimmune outlines PERFORMA Phase III MASH 52-week data readout expected in 2029 while advancing AUD Phase III planning
Northrop Grumman, Aeronix invest in space-based encryption technology
DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?
DXCM's 2026 rebound is backed by stronger growth, G7 15 Day adoption and broader CGM access, but competition and reimbursement remain key risks.
DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?
DexCom's 52.5% three-month rally is backed by earnings growth and margin gains, but premium valuation, competition and litigation raise the bar.
Is DLR Worth Buying as Growth Accelerates but Valuation Stays Rich?
DLR's growth outlook is strengthening on AI, cloud and enterprise demand, but rich valuation and a larger development program raise execution stakes.